成員

YAS Lab 的研究人員、學生與校友。

計畫主持人

沈耀安 博士

沈耀安 博士

副教授 · 臺北醫學大學 醫學院 病理學科/臨床醫學研究所/國際醫學碩博士學位學程

沈博士以第一名的成績畢業於國立陽明大學生化暨分子生物研究所博士班,之後前往約翰霍普金斯大學進行博士後研究,專攻癌症幹細胞與轉譯醫學。

為了連結基礎科學與臨床應用,他致力於解析癌症幹細胞的作用機制——這群細胞具有抗藥性,且會造成腫瘤復發與轉移。他的目標是開發創新的治療策略,涵蓋免疫細胞治療、轉錄因子抑制劑與奈米醫學。

沈博士是 Sigma Xi 科學研究榮譽學會正式會員,曾獲 9 次青年研究學者獎,研究成果發表於 Blood、ACS Nano、Cancer Research、EBioMedicine、J Exp Clin Cancer Res、Cell Reports 等期刊。他也擁有超過 10 項細胞治療、小分子藥物、囊泡藥物與奈米藥物相關專利,並於 2024 年創立 Enlighten Biomedicine,將癌症幹細胞研究轉化為醫療應用。

目前擔任臺北醫學大學副教授,持續推動癌症幹細胞研究與新一代腫瘤治療的發展。

學歷

  • 2009–2015PhD, Institute of Biochemistry and Molecular Biology, National Yang-Ming University
  • 2007–2009MS, Department of Life Sciences and Institute of Genome Sciences, National Yang-Ming University
  • 2000–2004BS, Department of Life Science, Tzu Chi University

研究專長

  • Translational Research — Small molecule inhibitors targeting GLS and PBX1 as cancer therapeutics
  • Cell Therapy — Stem cells for regenerative medicine and immune cells for anti-cancer therapy
  • Cancer Metabolism — Metabolic compensation and the microenvironmental landscape of therapy-resistant cells
  • Cancer Stem Cell Research — Metabolic reprogramming of cancer stem cells and biomarker discovery for targeted therapy
  • Induced Pluripotent Stem Cells — Metabolic reprogramming and anti-cancer applications of iPSCs
  • Nanomedicine — Targeted delivery systems of nanobiomaterials for cancer stem cell treatment

經歷

  • 2024.02–presentAssociate Professor, Department of Pathology / Graduate Institute of Clinical Medicine / International Master Program in Medicine, Taipei Medical University
  • 2019.06–2024.02Assistant Professor, Department of Pathology / Graduate Institute of Clinical Medicine / International Master Program in Medicine, Taipei Medical University
  • 2016.08–2019.06Postdoctoral Fellow, Departments of Pathology, Oncology, and Gynecology & Obstetrics, Johns Hopkins Medical Institutions, Baltimore, MD, USA
  • 2015.08–2016.07Postdoctoral Fellow, Department of Biomedical Engineering, National Yang-Ming University
  • 2015.02–2015.07Postdoctoral Fellow, Section of Gynecologic Oncology, Department of Obstetrics and Gynecology, Taipei Veterans General Hospital

授課科目

General Biology, General Chemistry, Biochemistry and Molecular Biology, Molecular Pathology, Genetics, Bioenergetics and Metabolism, Cancer Stem Cell Biology, Stem Cell Biology, Translational Medicine, Development of Cancer Therapeutics, Problem-Based Learning, Critical Thinking and Research Design

研究計畫 (10)

  • 2025.01–2029.12PI — Development of Acid-Responsive Mesoporous Silica Nanoparticles for Delivery of PBX1 Inhibitors Targeting Cancer Stem Cell Transcriptional ActivityNational Health Research Institutes (NHRI-EX114-11404E1)
  • 2024.08–2028.07PI — Utilizing Glucosamine-Labeled Nanodrugs as a Novel Pancreatic Cancer Stem Cell Therapy to Counteract Metabolic Compensation and Synergistically Inhibit Transcriptional ActivityNational Science and Technology Council (NSTC 113-2628-B-038-012)
  • 2024.01–2024.12PI — Commercial Applications of Technique Platform Development for Cancer Stem Cell Isolation and Cell TherapyNational Science and Technology Council (NSTC 113-2823-8-038-001)
  • 2023.08–2024.07PI — Investigation on the Synergistic Effect of a Combination of PCSK9 Inhibitors and Hyperthermia in Hepatic Cancer Stem CellsNational Science and Technology Council (NSTC 112-2314-B-038-081)
  • 2023.01–2023.12PI — Technique Platform Development for Cancer Stem Cell Isolation and Cell TherapyNational Science and Technology Council (NSTC 112-2823-8-038-001)
  • 2022.08–2023.07PI — Development of First-in-class Transcription Factor Drug Targeting Cancer Stem CellsNational Science and Technology Council (NSTC 111-2622-B-038-008)
  • 2021.04–2022.04Co-PI — Investigation of Hyperthermia Effects on Tumor Metabolism and Microenvironment in Radioresistant Bladder CancerTaipei Medical University Hospital (110TMU-TMUH-02-2)
  • 2020.12–2023.11PI — Investigation of Metabolic Isolation of Stem Cells and Its Effects on Differentiation Therapy of Cancer Stem CellsI CARE YOU Biotech (A-109-084)
  • 2020.02–2022.07PI — Reversing Metabolic Compensation to Overcome Recurrence in Ovarian Cancer by Inhibition of MYC/GLS AxisMinistry of Science and Technology (MOST 109-2314-B-038-021-MY3)
  • 2019.09PI — Research Grants for Newly Hired FacultyTaipei Medical University (TMU108-AE1-B12)

榮譽與獎項 (14)

  • 2024.08Elected full member of Sigma Xi, the Scientific Research Honor Society
  • 2023.05Licensing & technology transfer of 8 patents on cell expansion and metabolic selection techniques (I CARE YOU Biotech)
  • 2016.11Postdoctoral Research Abroad Program (PRAP) Award, Ministry of Science and Technology, Taiwan
  • 2013.11Young Investigator Award, International Symposium on Mitochondria 2013 / 13th Conference of J-mit, Japan
  • 2013.11Young Investigator Award, 10th Conference of the Asian Society of Mitochondrial Research and Medicine (ASMRM), Korea
  • 2013.10First Prize, Poster Award, 2013 Mini-symposium on Mitochondria and Aging, Taiwan
  • 2013.10Young Investigator Award, 6th Biennial Meeting of SFRR-Asia, Taiwan
  • 2013.09Third Prize, Poster Award, 2013 International Symposium on Mitochondrial Dynamics in Translational Medicine, Taiwan
  • 2012.11Young Investigator Award, 9th ASMRM Conference, Beijing, China
  • 2012.10Silver Medal, Oral Session Competition, 7th International Symposium on Genomic Medicine of CCH, Taiwan
  • 2011.10Fellowship Award, 22nd FAOBMB Conference, Singapore
  • 2011.08Young Investigator Award, 8th ASMRM Conference, Kagoshima, Japan
  • 2011.07First Prize, Poster Award, 2011 Mackay International Symposium on Mitochondrial Medicine, Taipei, Taiwan
  • 2010.12Young Investigator Award, 7th ASMRM Conference, Fukuoka, Japan

專利 (5)

  • 2024.12A method for expanding circulating tumor cells and applications thereofTaiwan I865391
  • 2024.10Cancer stem cell serum-free conditioned medium, and use thereof in a quadruple selecting method for cancer stem cell line, and the isolated cancer stem cell lineTaiwan I858897
  • 2024.09PRP-plus and its preparation method and useTaiwan I856429
  • 2024.05Peripheral blood stem cell amplification methodTaiwan I843445
  • 2021.08Monosaccharide-tagged nano-liposome drug delivery system, the manufacture and use for drug targeting delivery thereofTaiwan I734987; PCT/CN2019/088142

現任成員

現任成員

研究人員 4 位

  • Hung-Chung Chang

    博士後研究員

    Business Development

  • George Cheng

    研究員

    R&D

  • Ho Thi Luu

    博士後研究員

  • Kyle Cheng

    醫師

    R&D

研究生 7 位

  • Ray Chang

    博士生

  • Yuyu Rahayu Arifin

    博士生

  • Dinesh Kute

    博士生

  • Eman Fatima

    博士生

  • Yuki

    博士生

  • Nguyen Dinh Thien

    博士生

  • Jamie Lin

    碩士生・實驗室管理

醫學生 12 位

  • Allison莊晰之

    醫學生

  • Albert吳道賢

    醫學生

  • Heidi李彩禕

    醫學生

  • Tiffany曾馨儀

    醫學生

  • Angelina陳安晴

    醫學生

  • Mina洪子宸

    醫學生

  • Mimi楊岱穎

    醫學生

  • Amber林詠芯

    醫學生

  • Maus陳竤宇

    醫學生

  • Andy許和晏

    醫學生

  • Anna楊詠晴

    醫學生

  • Keynes邱楷恩

    醫學生

校友

校友

  • Ho Thi Luu

    博士班

    2022–2026

    現況Postdoctoral Fellow at YAS Lab

  • Viet-Cuong Nguyen

    博士班

    2023–2026

    現況—

  • Jane Tien Phan

    碩士生

    2023–2025

    現況—

  • Liang-Yun Chen

    醫學生

    2023–2025

    現況PGY at SHH

  • Ting-Wan Kao

    碩士生

    2023–2024

    現況Master's student at Harvard Medical School

  • Geng-Hao Bai

    醫學生

    —

    現況Resident at NTUH